Antimicrobial compositions comprising modified clay and nonionic triblock copolymers

US11857655B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11857655-B2
Application numberUS-201917414270-A
CountryUS
Kind codeB2
Filing dateNov 25, 2019
Priority dateDec 21, 2018
Publication dateJan 2, 2024
Grant dateJan 2, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is in the field of antimicrobial compositions, e.g. for personal care. In particular, the invention relates to antimicrobial compositions for oral care, such as toothpastes, comprising antimicrobial particles and a nonionic triblock copolymer. Accordingly, the present invention relates to antimicrobial compositions comprising a modified clay particle, the particle comprising an antimicrobial compound and a clay particle, and at least one a nonionic triblock copolymer. The invention further relates to the uses and methods of the antimicrobial compositions of the invention.

First claim

Opening claim text (preview).

The invention claimed is: 1. An antimicrobial composition comprising: a) a modified clay particle comprising an antimicrobial compound, the modified clay particle comprising: (i) an asymmetric 1:1 or 2:1:1 clay particle comprising alternating tetrahedral and octahedral sheets terminating with a tetrahedral sheet at one external surface plane and an octahedral sheet at another external surface plane, and (ii) at least one orally acceptable antimicrobial compound selected from a quaternary ammonium material selected from cetylpyridinium chloride (CPC), cetyltrimethylammonium chloride (CTAC), cetyltrimethylammonium bromide (CTAB), benzalkonium chloride (BKC), benzethonium chloride, cetrimide, quaternium, polyhexamethylene BH; antimicrobial alcohols; antimicrobial phenols; antimicrobial organic acids/salts; zinc pyrithione; ketoconazole; piroctone olamine; or combinations thereof, wherein the at least one antimicrobial compound is attached to a coordinating cation on an external surface plane of the clay particle; and b) a nonionic triblock copolymer, wherein the at least one antimicrobial compound is a quaternium ammonium material. 2. The composition according to claim 1 , wherein the at least one antimicrobial compound is attached to coordinating cations on the external surface of the octahedral surface plane. 3. The composition according to claim 1 , wherein clay:antimicrobial ratio is of between 1:0.001 to 1:0.1. 4. The composition according to claim 1 , wherein the antimicrobial particle is in the range of 0.01-5% by weight of the composition. 5. The composition according to claim 1 , wherein the nonionic triblock copolymer is poloxamer of general formula I: wherein b is an integer such that the hydrophobic base represented by (C 3 H 6 O) has a molecular weight of about 2750 to 4000, a is an integer such that the hydrophilic portion (moiety) represented by (C 2 H 4 O) constitutes about 70-80% by weight of the copolymer. 6. The composition according to claim 5 , wherein the nonionic triblock copolymer is a poloxamer of general formula I wherein a is 101 and b is 56. 7. The composition according to claim 1 , wherein the amount of nonionic triblock copolymer is in the range of 0.01 to 10% by weight of the composition. 8. The composition according to claim 1 , wherein the composition further comprises 1 to 80%, by total weight of the composition, of a surfactant. 9. The composition according to claim 1 , wherein the composition comprises one or more pharmaceutically acceptable component. 10. The composition according to claim 1 , wherein the composition is included in an oral care product selected from toothpaste, dentifrice, tooth powder, topical oral gel, mouth rinse, denture product, mouth spray, lozenge, oral tablet, chewing gum, impregnated dental implement, dental floss, and combinations thereof. 11. An antimicrobial composition, according to claim 1 , for use in the prevention or treatment of a disease of a mammal. 12. An antimicrobial composition, according to claim 1 , for use in the removal of oral biofilm in a mammal subject. 13. A non-therapeutic method of treating the skin and/or oral cavity of a mammal, the method including the step of contacting the skin and/or oral cavity of a mammal with the antimicrobial composition according to claim 1 . 14. An antimicrobial composition, according to claim 1 , for use in the prevention or treatment of a disease in the oral cavity selected from the group comprising caries, tartar, dental plaque, gum diseases, and combinations thereof.

Assignees

Inventors

Classifications

  • Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay} · CPC title

  • Pyridinium derivatives, e.g. pralidoxime, pyridostigmine · CPC title

  • A61K8/25Primary

    Silicon; Compounds thereof · CPC title

  • Quaternary ammonium compounds (A61K8/35 takes precedence) · CPC title

  • Polyethers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11857655B2 cover?
The present invention is in the field of antimicrobial compositions, e.g. for personal care. In particular, the invention relates to antimicrobial compositions for oral care, such as toothpastes, comprising antimicrobial particles and a nonionic triblock copolymer. Accordingly, the present invention relates to antimicrobial compositions comprising a modified clay particle, the particle comprisi…
Who is the assignee on this patent?
Conopco Inc
What technology area does this patent fall under?
Primary CPC classification A61K8/25. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).